ArticleMolecules (Basel, Switzerland)2022

Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.

Mehmet Abdullah Alagöz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.